<?xml version="1.0" encoding="UTF-8"?>
<study api_version="0.6">
  <id>3257</id>
  <name>GDAP_XTEN</name>
  <active>true</active>
  <user_id>137</user_id>
  <followers>
    <follower>
      <login>dw2</login>
      <email>dw2@sanger.ac.uk</email>
      <name>Danielle Walker</name>
      <id>86</id>
    </follower>
    <follower>
      <login>njl</login>
      <email>njl@sanger.ac.uk</email>
      <name>Nicola Corton</name>
      <id>98</id>
    </follower>
  </followers>
  <managers>
    <manager>
      <login>sarah</login>
      <email>sarah</email>
      <name>Sarah Sims</name>
      <id>137</id>
    </manager>
  </managers>
  <owners>
    <owner>
      <login>cp8</login>
      <email>cp8@sanger.ac.uk</email>
      <name>Cristina Pomilla</name>
      <id>584</id>
    </owner>
  </owners>
  <!-- Family has been deprecated -->
  <family_id></family_id>
  <created_at>2014-08-05 11:12:46 +0100</created_at>
  <updated_at>2014-08-06 15:00:29 +0100</updated_at>
  <descriptors>
    <descriptor>
      <name>Study description</name>
      <value>Globally, human populations show structured genetic diversity as a result of geographical dispersion, selection and drift. Understanding this genetic variation can provide insights into the evolutionary processes that shape both human adaptation and variation in disease. Populations from Africa have the highest levels of genetic diversity. This characteristic, in addition to historical genetic admixture, can lead to complexities in the design of studies assessing the genetic determinants of disease and human variation. However, such studies of African populations are also likely to provide new opportunities to discover novel disease susceptibility loci and variants and refine gene&#8211;disease association signals. A systematic assessment of genetic diversity within Africa would facilitate genomic epidemiological studies in the region.
The GDA Project focus on sequencing the whole genome of less studied, genetically diverse groups within Africa with the objective of detailed characterisation of genetic variation within Africa. As part of this effort we propose to sequence at high depth (30x) on the Illumina X Ten platform nine individuals, including family trios wherever possible, from three distinct ethno-linguistic groups.
This set of nine high depth genomes will serve as a high-confidence set to validate calling and filtering of variants in lower depth data. Additionally, it will complement existing data from the Human Genome Diversity Project (HGDP). A family-based design might also serve other projects (e.g. estimating TMRCA or mutation rate).
</value>
    </descriptor>
    <descriptor>
      <name>Does this study contain samples that are contaminated with human DNA which must be removed prior to analysis?</name>
      <value>No</value>
    </descriptor>
    <descriptor>
      <name>Does this study require the removal of X chromosome and autosome sequence?</name>
      <value>No</value>
    </descriptor>
    <descriptor>
      <name>Does this study require y chromosome data to be separated from x and autosomal data before archival?</name>
      <value>false</value>
    </descriptor>
    <descriptor>
      <name>ENA Project ID</name>
      <value></value>
    </descriptor>
    <descriptor>
      <name>Abstract</name>
      <value>The GDA Project focus on sequencing the whole genome of less studied, genetically diverse groups within Africa with the objective of detailed characterisation of genetic variation within Africa. As part of this effort we propose to sequence at high depth (30x) on the Illumina X Ten platform nine individuals, including family trios wherever possible, from three distinct ethno-linguistic groups.
This set of nine high depth genomes will serve as a high-confidence set to validate calling and filtering of variants in lower depth data. Additionally, it will complement existing data from the Human Genome Diversity Project (HGDP). A family-based design might also serve other projects (e.g. estimating TMRCA or mutation rate).
</value>
    </descriptor>
    <descriptor>
      <name>Title</name>
      <value>GDAP  High depth sequencing (Illumina X Ten)</value>
    </descriptor>
    <descriptor>
      <name>ENA Study Accession Number</name>
      <value>EGAS00001000929</value>
    </descriptor>
    <descriptor>
      <name>Study Visibility</name>
      <value>Hold</value>
    </descriptor>
    <descriptor>
      <name>Do any of the samples in this study contain human DNA?</name>
      <value>Yes</value>
    </descriptor>
    <descriptor>
      <name>Are all the samples to be used in this study commercially available, unlinked anonymised cell-lines?</name>
      <value>No</value>
    </descriptor>
    <descriptor>
      <name>Study name abbreviation</name>
      <value>gdap_xten</value>
    </descriptor>
    <descriptor>
      <name>What is the data release strategy for this study?</name>
      <value>managed</value>
    </descriptor>
    <descriptor>
      <name>Will you be using WTSI's standard access agreement?</name>
      <value>Yes</value>
    </descriptor>
    <descriptor>
      <name>How is the data release to be timed?</name>
      <value>standard</value>
    </descriptor>
    <descriptor>
      <name>Reason for delaying release</name>
      <value></value>
    </descriptor>
    <descriptor>
      <name>Delay for</name>
      <value></value>
    </descriptor>
    <descriptor>
      <name>Alignments in BAM</name>
      <value>true</value>
    </descriptor>
    <descriptor>
      <name>Please explain the reason for delaying release</name>
      <value></value>
    </descriptor>
    <descriptor>
      <name>Comment regarding data release timing and approval</name>
      <value></value>
    </descriptor>
    <descriptor>
      <name>Policy Url</name>
      <value>https://www.sanger.ac.uk/datasharing/</value>
    </descriptor>
    <descriptor>
      <name>Policy title</name>
      <value>Wellcome Trust Sanger Institute Data Sharing Policy</value>
    </descriptor>
    <descriptor>
      <name>EGA DAC Accession Number</name>
      <value></value>
    </descriptor>
    <descriptor>
      <name>EGA Policy Accession Number</name>
      <value></value>
    </descriptor>
    <descriptor>
      <name>ArrayExpress Accession Number</name>
      <value></value>
    </descriptor>
    <descriptor>
      <name>Has the delay period been approved by the data sharing committee for this project?</name>
      <value></value>
    </descriptor>
    <descriptor>
      <name>What is the reason for preventing data release?</name>
      <value></value>
    </descriptor>
    <descriptor>
      <name>Has this been approved?</name>
      <value></value>
    </descriptor>
    <descriptor>
      <name>Comment regarding prevention of data release and approval</name>
      <value></value>
    </descriptor>
    <descriptor>
      <name>Data access group</name>
      <value></value>
    </descriptor>
    <descriptor>
      <name>SNP study ID</name>
      <value></value>
    </descriptor>
    <descriptor>
      <name>SNP parent study ID</name>
      <value></value>
    </descriptor>
    <descriptor>
      <name>Number of gigabases per sample (minimum 0.15)</name>
      <value></value>
    </descriptor>
    <descriptor>
      <name>HMDMC approval number</name>
      <value></value>
    </descriptor>
    <descriptor>
      <name>Study Type</name>
      <value>Whole Genome Sequencing</value>
    </descriptor>
    <descriptor>
      <name>What sort of study is this?</name>
      <value>genomic sequencing</value>
    </descriptor>
    <descriptor>
      <name>Reference Genome</name>
      <value>Homo_sapiens (1000Genomes_hs37d5)</value>
    </descriptor>
    <descriptor>
      <name>Faculty Sponsor</name>
      <value>Manj Sandhu</value>
    </descriptor>
  </descriptors>
</study>
